English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Levamlodipine, a calcium channel blocker, has been show act as a cardiovascular drug. To compare the pharmacokinetic parameters between levamlodipine (test formulation) at a single dose of 5 mg and amlodipine (reference formulation) at a single dose of 10 mg, the bioequivalence study was carried out.    Methods  A single-dose randomized, open-label, two-period crossover study was designed in healthy Chinese subjects. 48 subjects were divided into fasted and fed groups equally. The subjects randomly received the test or reference formulations at the rate of 1:1. Following a 21-day washout period, the alternative formulations were received. The blood samples were collected at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 24, 36, 48, 72, 96, 120, 144, 168 h later. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was applied to determine the plasma concentrations of levamlodipine. Adverse events were recorded.    Results  The 90% confidence intervals (CIs) of the ratio of geometric means (GMRs) of C max , AUC 0-t , and AUC 0-∞  under both fasted and fed conditions were within the prespecified bioequivalence limits between 80 ~ 125%. Under fasted conditions, 24 subjects were enrolled and completed the study. The mean C max  was (2.70 ± 0.49) ng/mL, AUC 0-t  was (141.32 ± 36.24) ng × h/mL and AUC 0-∞  was (157.14 ± 45.65) ng × h/mL after a single dose of 5 mg levamlodipine. The mean C max  was (2.83 ± 0.52) ng/mL, AUC 0-t  was (153.62 ± 33.96) ng × h/mL and AUC 0-∞  was (173.05 ± 41.78) ng × h/mL after a single dose of 10 mg amlodipine. Under fed conditions, 24 subjects were enrolled and completed the study. The mean C max  was (2.73 ± 0.55) ng/mL, AUC 0-t  was (166.93 ± 49.96) ng × h/mL and AUC 0-∞  was (190.99 ± 70.89) ng × h/mL after a single dose of 5 mg levamlodipine. The mean C max  was (2.87 ± 0.81) ng/mL AUC 0-t  was (165.46 ± 43.58) ng × h/mL and AUC 0-∞  was (189.51 ± 64.70) ng × h/mL after a single dose of 10 mg amlodipine. Serious adverse event was not observed.    Conclusion  The trial confirmed that levamlodipine at a single dose of 5 mg and amlodipine at a single dose of 10 mg were bioequivalent under both fasted condition and fed condition.    Trial registration  Cinicaltrials,  NCT04411875 . Registered 3 June 2020 - Retrospectively registered    Supplementary Information  The online version contains supplementary material available at 10.1186/s40360-020-00459-6.

Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study